Are you incorporating automated systems in your facility but concerned about how to increase quality outcomes using automated systems? Automation systems implemented correctly can provide a more robust quality system and improve drug quality. Hear from outsourcing facility executives and consultants who will share their perspectives on how they manage change as they balance incorporating automation with promoting quality and maintaining current good manufacturing practice requirements and the quality considerations of incorporating potential efficiencies.
The Quality Discussion Series is tailored for outsourcing facilities interested in advancing quality and will focus on topics related to quality culture and best practices. These discussions will take place several times a year and aim to build a robust community of outsourcing facilities with a strong commitment to quality and current good manufacturing practice requirements. This series also provides the industry with an opportunity to share quality practices across the industry that positively impact patient safety.
This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of an award of $60,848 in federal funds (100% of the project). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA, HHS, or the U.S. Government. For more information, please visit FDA.gov.